To investigate the impact of CXCL4 on the development of tumour metastasis, we administered recombinant CXCL4 to wild-type BALB/c mice immediately after the implantation of non-metastatic 67NR tumours in the mammary fat pad and every other day throughout the establishment of tumours. The gene discussed is PF4; the disease is neoplasm.